Research Funding

National cancer gene therapy foundation announces $1.5 million in grants

Published in Gene Therapy Weekly, March 27th, 2003

Alliance for Cancer Gene Therapy, Inc. (ACGT), a national foundation based in Stamford, Connecticut, has announced the awarding of its 2002 national grants to three young investigators at major research institutions. The grants, totaling $1.5 million over 3 years, relate to separate cancer gene therapy research projects involving neuroblastoma, prostate, and ovarian cancers.

The recipients of the 2002 awards are Dr. Andrew Davidoff at St. Jude Children's Research Hospital, Memphis, Tennessee, for the development of antiangiogenic gene therapy for neuroblastoma, a deadly form of childhood cancer; Dr. Thomas Griffith at the University of Iowa for development and testing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry